Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 35
2017 289
2018 404
2019 464
2020 688
2021 575
2022 686
2023 832
2024 385

Text availability

Article attribute

Article type

Publication date

Search Results

4,355 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.
Opat S, Tedeschi A, Hu B, Linton KM, McKay P, Leitch S, Coleman M, Zinzani PL, Jin J, Sun M, Sobieraj-Teague M, Browett P, Ke X, Thieblemont C, Ardeshna K, Bijou F, Walker P, Hawkes EA, Ho SJ, Zhou K, Liang Z, Xu J, Tankersley C, Delarue R, Co M, Trotman J. Opat S, et al. Blood Adv. 2023 Nov 28;7(22):6801-6811. doi: 10.1182/bloodadvances.2023010668. Blood Adv. 2023. PMID: 37682792 Free PMC article. Clinical Trial.
AMPK activation induces immunogenic cell death in AML.
Mondesir J, Ghisi M, Poillet L, Bossong RA, Kepp O, Kroemer G, Sarry JE, Tamburini J, Lane AA. Mondesir J, et al. Blood Adv. 2023 Dec 26;7(24):7585-7596. doi: 10.1182/bloodadvances.2022009444. Blood Adv. 2023. PMID: 37903311 Free PMC article.
Vitamin C and D supplementation in acute myeloid leukemia.
Mouchel PL, Bérard E, Tavitian S, Gadaud N, Vergez F, Rieu JB, Luquet I, Sarry A, Huguet F, Largeaud L, Delabesse E, Huynh A, Bertoli S, Récher C. Mouchel PL, et al. Blood Adv. 2023 Nov 28;7(22):6886-6897. doi: 10.1182/bloodadvances.2023010559. Blood Adv. 2023. PMID: 37671973 Free PMC article.
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment.
Jian Y, Chang L, Shi MX, Sun Y, Chu XX, Xue H, Huang WR, Shen XL, Ma J, Jia GR, Feng YQ, Xi ZF, Zhao YH, Ma YP, Xiao J, Ma GY, Wang QM, Bao L, Dong YJ, Zhou HB, Sun CY, Su GH, Yan Y, Qimuge SY, Su LP, Sun JN, Tian WW, Sun XL, Ing HM, Gao D, Chen WM, Li J, Gao W. Jian Y, et al. Blood Adv. 2023 Dec 26;7(24):7581-7584. doi: 10.1182/bloodadvances.2023011428. Blood Adv. 2023. PMID: 37922425 Free PMC article. No abstract available.
Natalizumab for GVHD: too little or too late?
Quann K, Sacirbegovic F, Shlomchik WD. Quann K, et al. Blood Adv. 2023 Sep 12;7(17):5187-5188. doi: 10.1182/bloodadvances.2023010486. Blood Adv. 2023. PMID: 37698891 Free PMC article. No abstract available.
4,355 results